Insulin for Hyperglycemia in Stroke Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 452 participants.

Also called NCT04834362

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 452 participants (enrolled count) (from the registry)
Sponsor
National Institute of Neurosciences and Hospital, Dhaka (from the registry)
Registry
  • NCT NCT04834362
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Bangladesh (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04834362. Randomized; no masking; primary purpose treatment. Start 2021-04-05 (actual); primary completion 2021-06-20 (actual). Results posted on 2021-12-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Insulin for Hyperglycemia in Stroke Trial
Condition
Hyperglycemia
Condition
Stroke, Acute
Intervention (Drug)
Analog Insulin
Intervention (Drug)
Human insulin
Lead sponsor
National Institute of Neurosciences and Hospital, Dhaka (class: other government)

Record details

Record id
cardio:ct-nct04834362
Content hash
07cceff8e7432065a8205100c468fd5ac2b118e5478d1a3b36ffe51759ae2e28